| Date | Time | Room | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|---|
| 09/03/2018 | 13:40 to 16:40 | Sala 1 |
Leucemia Linfocítica Crônica (LLC) Palestra - Chronic lymphocytic leukemia (CLL) (13) |
14:20 to 14:40 | My 67-year old patient relapsed 18 months after FCR. Should I consider newer biologic agents? | Palestrante |
| 09/03/2018 | 13:40 to 16:40 | Sala 1 |
Leucemia Linfocítica Crônica (LLC) Palestra - Chronic lymphocytic leukemia (CLL) (13) |
15:00 to 15:20 | BTK failures | Palestrante |
| 09/03/2018 | 13:40 to 16:40 | Sala 1 |
Leucemia Linfocítica Crônica (LLC) Palestra - Chronic lymphocytic leukemia (CLL) (13) |
15:40 to 16:00 | My patient who progressed on ibrutinib is now starting to lose response to venetoclax. What should I do? | Palestrante |
| 09/03/2018 | 13:40 to 16:40 | Sala 1 |
Leucemia Linfocítica Crônica (LLC) Palestra - Chronic lymphocytic leukemia (CLL) (13) |
16:15 to 16:20 | What’s in the future in CLL | Palestrante |